Ute Schütte

489 total citations
8 papers, 386 citations indexed

About

Ute Schütte is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ute Schütte has authored 8 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Ute Schütte's work include Pancreatic and Hepatic Oncology Research (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ute Schütte is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ute Schütte collaborates with scholars based in Germany, United States and Switzerland. Ute Schütte's co-authors include Jun Zhou, Gëorge F. Murphy, F. Stephen Hodi, Giulio C. Spagnoli, Natasha Y. Frank, Markus H. Frank, André Hoerning, Tobias Schatton, Qian Zhan and Georg Feldmann and has published in prestigious journals such as Cancer Research, Histopathology and Methods in molecular biology.

In The Last Decade

Ute Schütte

8 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ute Schütte Germany 6 266 169 162 79 50 8 386
Takeshi Terui Japan 6 181 0.7× 125 0.7× 123 0.8× 34 0.4× 48 1.0× 8 278
Judith Vinaixa Spain 5 193 0.7× 157 0.9× 162 1.0× 28 0.4× 54 1.1× 6 341
Gregory P. Chang United States 3 291 1.1× 180 1.1× 311 1.9× 44 0.6× 48 1.0× 3 538
Pauline L. de Goeje Netherlands 6 196 0.7× 136 0.8× 155 1.0× 32 0.4× 44 0.9× 6 375
Geoffrey Richard France 4 233 0.9× 287 1.7× 73 0.5× 66 0.8× 67 1.3× 5 417
Caroline Liot France 7 252 0.9× 291 1.7× 194 1.2× 105 1.3× 62 1.2× 7 549
Arnaud Pommier France 9 216 0.8× 133 0.8× 342 2.1× 72 0.9× 66 1.3× 12 537
Erika M. von Euw United States 7 228 0.9× 221 1.3× 196 1.2× 28 0.4× 27 0.5× 15 423
Mireia Vallespinós Spain 5 164 0.6× 155 0.9× 143 0.9× 24 0.3× 68 1.4× 8 324
Maria Semiannikova United Kingdom 4 154 0.6× 148 0.9× 93 0.6× 37 0.5× 56 1.1× 4 269

Countries citing papers authored by Ute Schütte

Since Specialization
Citations

This map shows the geographic impact of Ute Schütte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Schütte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Schütte more than expected).

Fields of papers citing papers by Ute Schütte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Schütte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Schütte. The network helps show where Ute Schütte may publish in the future.

Co-authorship network of co-authors of Ute Schütte

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Schütte. A scholar is included among the top collaborators of Ute Schütte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Schütte. Ute Schütte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Schatton, Tobias, Ute Schütte, & Markus H. Frank. (2015). Effects of Malignant Melanoma Initiating Cells on T-Cell Activation. Methods in molecular biology. 2 indexed citations
2.
Bisht, Savita, Jens Nolting, Ute Schütte, et al.. (2015). Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread—Identification of a Promising Novel therapeutic target. Translational Oncology. 8(4). 295–307. 27 indexed citations
3.
Schütte, Ute, Savita Bisht, Lukas C. Heukamp, et al.. (2014). Hippo Signaling Mediates Proliferation, Invasiveness, and Metastatic Potential of Clear Cell Renal Cell Carcinoma. Translational Oncology. 7(2). 309–321. 66 indexed citations
4.
Lehnen, Nils, Anne von Mäßenhausen, Holger Kalthoff, et al.. (2013). Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma. Histopathology. 63(2). 157–166. 36 indexed citations
5.
Feldmann, Georg, et al.. (2012). Everolimus for the treatment of pancreatic neuroendocrine tumors. Expert Opinion on Pharmacotherapy. 13(14). 2073–2084. 5 indexed citations
6.
Schatton, Tobias, Ute Schütte, Natasha Y. Frank, et al.. (2010). Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells. Cancer Research. 70(2). 697–708. 238 indexed citations
7.
Schütte, Ute, Savita Bisht, Peter Brossart, & Georg Feldmann. (2010). Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational research. Expert Opinion on Drug Discovery. 6(1). 33–48. 11 indexed citations
8.
Schatton, Tobias, Ute Schütte, Natasha Y. Frank, et al.. (2010). Abstract 4286: Modulation of T cell activation by malignant melanoma initiating cells. Cancer Research. 70(8_Supplement). 4286–4286. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026